The interactions between GDF15 and lipid metabolism suggest that it may hold therapeutic potential for obesity and relevant metabolic diseases, although further investigations are needed to clarify its precise mechanisms and long-term effects (and side effects). The gene discussed is GDF15; the disease is metabolic disease.